[GUEST ACCESS MODE: Data is scrambled or limited to provide examples. Make requests using your API key to unlock full data. Check https://lunarcrush.ai/auth for authentication information.]

@BioStocks Avatar @BioStocks Bio Stocks™

Bio Stocks™ posts on X about $kymr, $tern, $xbi, $rytm the most. They currently have XXXXXX followers and XXX posts still getting attention that total XXXXXX engagements in the last XX hours.

Engagements: XXXXXX #

Engagements Line Chart

Mentions: XX #

Mentions Line Chart

Followers: XXXXXX #

Followers Line Chart

CreatorRank: XXXXXXX #

CreatorRank Line Chart

Social Influence

Social category influence finance XXXXX% stocks XXXXX% cryptocurrencies #5232 currencies XXX% vc firms #257 technology brands XXX%

Social topic influence $kymr #2, $tern #1, $xbi #8, $rytm #17, $350m #3, $lly #10, $barcl #82, $wve #5, $ocul #6, $dyn #1

Top accounts mentioned or mentioned by @mbrushstocks @biotechtoast @biopharmiq @fwcweather @tradingsssss @markettargetz @rnaianalyst @truedat999 @samfazeli8 @zipjet @biopharma_watch @biotech2k1 @jul05310473john @polycle @tim925256475865 @semodough @learnbiotech @m56804962 @pgainz96934 @jcannush

Top assets mentioned Kymera Therapeutics, Inc. Common Stock (KYMR) Terns Pharmaceuticals, Inc. Common Stock (TERN) Bitcoin Incognito (XBI) Rhythm Pharmaceuticals, Inc. Common Stock (RYTM) Eli Lilly and Company (LLY) Wave Life Sciences Ltd. Ordinary Shares (WVE) Ocular Therapeutix, Inc. (OCUL) Dyne Therapeutics, Inc. Common Stock (DYN) Novo-Nordisk (NVO) AstraZeneca PLC (AZN) Hims & Hers Health, Inc. (HIMS) Taraxa (TARA) Praxis Precision Medicines, Inc. Common Stock (PRAX) Dawn Protocol (DAWN) Alkermes Inc. plc (ALKS) Viking Therapeutics, Inc (VKTX) 501 (32) Sarepta Therapeutics, Inc. (SRPT) TG Therapeutics, Inc. (TGTX) Biogen Inc (BIIB) GoodRx Holdings, Inc. Class A Common Stock (GDRX) Alnylam Pharmaceuticals, Inc. (ALNY) Axsome Therapeutics, Inc (AXSM) Celcuity Inc. Common Stock (CELC) AltLayer (ALT) Dr. Reddy's Laboratories Limited American Depositary Shares (RDY) Arrowhead Research Corporation (ARWR) One Cash (ONC) Natera, Inc. Common Stock (NTRA) Insmed, Inc. (INSM) Teva Pharmaceutical Industries Limited American Depositary Shares (TEVA) Janux Therapeutics, Inc. Common Stock (JANX) Marblex (MBX) Goldman Sachs (GS) Incyte Corporation (INCY) Novartis AG (NVS)

Top Social Posts

Top posts by engagements in the last XX hours

"$AZN Baxdrostat NDA accepted under FDA Priority Review for patients with hard-to-control hypertension. PDUFA anticipated in Q2'26 following use of Priority Review voucher"
X Link 2025-12-02T14:20Z 70.5K followers, 5559 engagements

"$HIMS initiated with an Overweight at Barclays. PT $48"
X Link 2025-12-09T02:05Z 70.5K followers, 4093 engagements

"$TERN PT raised to $XX at Barclays"
X Link 2025-12-09T11:01Z 70.5K followers, 3685 engagements

"$TERN $400M offering"
X Link 2025-12-09T11:19Z 70.4K followers, 7132 engagements

"$SRPT initiated with an Outperform at Wedbush. PT $32"
X Link 2025-12-09T12:05Z 70.5K followers, 4632 engagements

"$TGTX Q3 EPS $XXXX beats $XXXX Est. Sales $161.7M beat $152M Est 🔥 Raises FY2025 Sales Guidance from $585M to $600M"
X Link 2025-11-03T12:03Z 70.5K followers, 5932 engagements

"Eisai Completes Rolling sBLA Submission for LEQEMBI IQLIK (lecanemab-irmb) as a Subcutaneous Starting Dose for the Treatment of Early Alzheimer's Disease Under Fast Track Status. $BIIB"
X Link 2025-11-25T12:36Z 70.5K followers, 4280 engagements

"$GDRX covg initiated with an Underweight at Barclays. PT $3"
X Link 2025-12-09T12:51Z 70.5K followers, 3530 engagements

"$ALNY Q3 total net product revenues of $851M. XXX% growth compared with Q3'24. Total TTR revenues of $724M. XXX% YoY"
X Link 2025-10-30T12:04Z 70.4K followers, 3967 engagements

"$AXSM obtains exclusive global rights to AZD7325 a novel oral GABAA receptor XX subtype-selective positive allosteric modulator (PAM) licensed from $AZN"
X Link 2025-11-06T12:02Z 70.4K followers, 4310 engagements

"$CELC completes NDA submission for Gedatolisib in HR+/HER2-/PIK3CA Wild-Type Advanced Breast Cancer. The NDA was submitted under the FDAs Real-Time Oncology Review (RTOR) program"
X Link 2025-11-17T23:08Z 70.4K followers, 4985 engagements

"$TARA Announces Positive Interim Results Demonstrating Robust Responses in the Ongoing Phase X STARBORN-1 Trial of TARA-002 in Pediatric Patients with Lymphatic Malformations"
X Link 2025-11-19T13:01Z 70.4K followers, 5494 engagements

"$380/yr. 🤑🤑"
X Link 2025-11-24T15:30Z 70.4K followers, 277.6K engagements

"$DARE Announces Return of Rights to Ovaprene by Bayer"
X Link 2025-12-01T13:03Z 70.4K followers, 4180 engagements

"$ALT CEO to step down effective Jan 1"
X Link 2025-12-01T13:26Z 70.4K followers, 4336 engagements

"$SPRB upgraded to Outperform at Leerink. PT $160"
X Link 2025-12-03T13:46Z 70.4K followers, 4018 engagements

"Indian Court Rejects $NVO's Injunction Plea Allows Dr. Reddy's to Manufacture and Export Generic Versions of Semaglutide. $RDY"
X Link 2025-12-04T11:46Z 70.4K followers, 5594 engagements

"$TARA $75M offering priced at $5.75/share"
X Link 2025-12-05T03:14Z 70.4K followers, 5082 engagements

"$KYMR KT-621 BROADEN2 Phase 2b trial in moderate to severe AD is ongoing with data expected by mid-2027. Phase 2b BREADTH trial in moderate to severe asthma patients is on track to start inQ1'26"
X Link 2025-12-08T12:08Z 70.4K followers, 4360 engagements

"$KYMR XX% PM"
X Link 2025-12-08T12:21Z 70.4K followers, 3158 engagements

"$ARWR Initiates Phase 1/2a Study of ARO-MAPT for the Treatment of Alzheimers Disease and Other Tauopathies"
X Link 2025-12-08T12:34Z 70.4K followers, 4512 engagements

"PM movers - $WVE XX% $FULC XX% $KYMR XX $OCUL XX% $DYN XX% $KMDA X% $XBI #biotech"
X Link 2025-12-08T12:54Z 70.4K followers, 11.5K engagements

"$PRAX PT raised to $XXX at Truist"
X Link 2025-12-08T13:14Z 70.4K followers, 2687 engagements

"$PRAX #AES25 Wrap-up: Best-in-Class Potential Across Rare Pediatric and Adult Epilepsies"
X Link 2025-12-08T13:27Z 70.4K followers, 3226 engagements

"$RYTM Q3 net product revenue from global sales of IMCIVREE of $51.3M -Preliminary data from Setmelanotide Phase X trial in Prader-Willi syndrome in Q4"
X Link 2025-11-04T12:10Z 70.4K followers, 3520 engagements

"$RYTM FDA requested additional sensitivity analyses of clinical efficacy data from Phase X pivotal trial in acquired hypothalamic obesity. No new data were requested. The additional information has been deemed a major amendment"
X Link 2025-11-07T12:32Z 70.4K followers, 6516 engagements

"$DAWN to Acquire $MRSN for $25/share cash + CVR"
X Link 2025-11-13T11:01Z 70.4K followers, 22.6K engagements

"$25/share in cash plus up to an aggregate of $30.25/share in cash potentially payable under the CVR for total consideration of up to $55.25/share in cash. $DAWN $MRSN"
X Link 2025-11-13T11:09Z 70.4K followers, 6696 engagements

"$RYTM initiated with a Buy at Citi. PT $136"
X Link 2025-11-25T11:11Z 70.4K followers, 3918 engagements

"$ONC FDA Grants Priority Review to Sonrotoclax NDA for the Treatment of Relapsed or Refractory Mantle Cell Lymphoma"
X Link 2025-11-26T11:03Z 70.4K followers, 4144 engagements

"$PYXS $350M shelf $150M ATM"
X Link 2025-11-26T14:47Z 70.4K followers, 4917 engagements

"30% of Billionaire Stanley Druckenmiller's Portfolio Is Invested in These X Biopharma Stocks $NTRA $INSM $TEVA $XBI"
X Link 2025-11-30T16:06Z 70.4K followers, 16.8K engagements

"$KYMR Announces Positive Results from BroADen Phase 1b Clinical Trial of KT-621 a First-in-Class Oral STAT6 Degrader in Patients with Moderate to Severe Atopic Dermatitis"
X Link 2025-12-08T12:01Z 70.4K followers, 25.8K engagements

"$CCCC Point72 Asset Management reports XXX% stake"
X Link 2025-10-21T01:05Z 70.5K followers, 10.1K engagements

"$CYBN $175M PIPE Venrock Partners OrbiMed Point72 Deep Track Capital Acorn Bioventures Spruce Street Capital Squadron Capital Adage Capital Boxer Capital ADAR1 Capital Management Stonepine Capital Management Pivotal Bioventure Partners Ally Bridge Group"
X Link 2025-10-28T12:03Z 70.5K followers, 21.8K engagements

"$AVDL Board Declares Lundbeck Proposal a Company Superior Proposal. $ALKS"
X Link 2025-11-17T10:53Z 70.5K followers, 9823 engagements

"$ALKS Announces Increased Offer to Acquire $AVDL $22.50/share - consisting of $21/share in cash + $XXXX CVR"
X Link 2025-11-19T11:02Z 70.5K followers, 6164 engagements

"$CBIO $185M PIPE. Forbion Fairmount Vestal Point Capital BVF Partners ADAR1 Balyasny Asset Management and Venrock Healthcare Capital"
X Link 2025-12-04T11:37Z 70.5K followers, 11.1K engagements

"$MBX initiated with a Sell at Goldman Sachs. PT $18"
X Link 2025-12-04T12:49Z 70.4K followers, 5724 engagements

"$OCUL AH vol"
X Link 2025-12-06T02:12Z 70.5K followers, 8824 engagements

"$MNOV $300M shelf $LUCD $175M shelf $MYNZ $150M shelf $RZLT shelf"
X Link 2025-12-06T04:33Z 70.4K followers, 4268 engagements

"$OCUL plans to leverage the 505(b)(2) regulatory pathway for new drug approvals which has the potential to shorten the review timeline for AXPAXLI"
X Link 2025-12-08T12:04Z 70.4K followers, 6150 engagements

"$INCY PT raised to $XXX at Wells Fargo"
X Link 2025-12-08T12:13Z 70.4K followers, 3036 engagements

"$NVS collaboration with Relation Therapeutics to discover and advance novel targets for atopic diseases. Relation to receive $55M upfront"
X Link 2025-12-09T10:25Z 70.4K followers, 5125 engagements

"$LLY Jaypirca (pirtobrutinib) significantly improved progression-free survival reducing the risk of progression or death by XX% versus chemoimmunotherapy in patients with treatment-nave CLL/SLL"
X Link 2025-12-09T12:43Z 70.5K followers, 4391 engagements

"$TERN $650M offering Whoa 16.25M shares at $40/share"
X Link 2025-12-10T04:36Z 70.5K followers, 5037 engagements

"#Biotech offerings priced - $TERN $650M at $40/share $GPCR $650M at $65/ADS $KYMR $602M at $86/share $WVE $350M at $19/share $DYN $350M at $18.44/share $VERA $261M at $42.50/share $XXXX Billion💥 $XBI"
X Link 2025-12-10T04:47Z 70.5K followers, 24.3K engagements

"$NVO Phase X trial with amycretin reports significant weight loss and HbA1c reduction in type X diabetes. Amycretin showed statistically significant weight loss of up to XXXX% at XX weeks. $LLY $VKTX"
X Link 2025-11-25T11:30Z 70.5K followers, 52.3K engagements

"Biotech Stocks Facing FDA Decision In December $AXGN $AGIO $BCRX $MIST $INVA $ALDX $OMER $CYTK $VNDA $CORT $OTLK $XBI"
X Link 2025-11-30T14:10Z 70.5K followers, 12.3K engagements

"$LLY cuts prices of Zepbound weight loss drug vials on direct-to-consumer site. Cash-paying patients with a valid prescription can pay $XXX to $XXX per month for Zepbound vials on LillyDirect. $NVO $HIMS"
X Link 2025-12-01T13:15Z 70.5K followers, 11.1K engagements

"$AXGN FDA Approves BLA for AVANCE"
X Link 2025-12-04T01:25Z 70.5K followers, 8854 engagements

"$DNLI and $RPRX Announce $275M Royalty Funding Agreement"
X Link 2025-12-04T12:01Z 70.5K followers, 3883 engagements

"$LUCD Announces Positive Data from the Largest Reported Real-World Experience of Esophageal Precancer Detection"
X Link 2025-12-09T13:02Z 70.4K followers, 11.5K engagements

"$DYN $350M offering priced at $XXXXX per share"
X Link 2025-12-10T02:49Z 70.5K followers, 3509 engagements

"$WVE $350M offering priced at $19/share"
X Link 2025-12-10T02:51Z 70.5K followers, 5643 engagements

"$LLY triple agonist Retatrutide delivered weight loss of up to an average of XXXX lbs along with substantial relief from osteoarthritis pain in first successful Phase X trial. $NVO $VKTX $GPCR"
X Link 2025-12-11T11:53Z 70.5K followers, 5496 engagements

"$RYTM Announces Preliminary Data from Exploratory Phase X Trial that showed Setmelanotide Demonstrated Positive Efficacy Signal in Prader-Willi Syndrome"
X Link 2025-12-11T12:31Z 70.5K followers, 4504 engagements